LEXX
Lexaria Bioscience Corp.
NASDAQ · Healthcare · Biotechnology · CA
$14.15
+14.85%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.93x
- Price / sales
- 120.53x
- Price / cash flow
- -3.15x
Enterprise value
- Enterprise value
- $19.5M
- EV / sales
- 100.30x
- EV / EBITDA
- -2.53x
- EV / EBIT
- -2.52x
- Market cap
- $23.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of May 1, 2026